Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Normarin Allergy is a hypertonic saline nasal spray (2.0% NaCl) developed by AICORE. It is specifically formulated for the relief of nasal congestion and the cleansing of nasal passages in individuals suffering from allergic rhinitis, hay fever, and sinusitis. The product works through a dual mechanism: an osmotic effect that draws excess fluid from the swollen nasal mucosa to reduce edema, and a mechanical action that flushes out allergens (such as pollen and dust), inflammatory mediators, and thick mucus. As a non-pharmacological, preservative-free solution, it is suitable for long-term use and can be used in combination with other allergy medications or as a standalone treatment for patients seeking drug-free relief.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Normarin Allergy.